Many recent studies have shown that AP4 is highly expressed in various types of tumor, including breast cancer [28], colorectal cancer [3,50], gastric cancer [32], pancreatic cancer [51], prostate cancer [52], non-small cell lung cancer [53], and hepatocellular carcinoma [54]. Here, TFAP4 is linked to prostate carcinoma.